Harrow (HROW) Intangibles (2014 - 2026)
Harrow's (HROW) quarterly Intangibles came in at $181.1 million in Q1 2026, down 13.2% year-on-year from $208.6 million in Q1 2025, and up 3.36% quarter-over-quarter from $175.2 million in Q4 2025.
Harrow (HROW) Intangibles (2014 - 2026) Analysis & Trends
Harrow's Intangibles history runs 13 years deep, the most recent figure standing at $181.1 million for Q1 2026.
- On a quarterly basis, Intangibles fell 13.2% year-over-year to $181.1 million in Q1 2026; TTM through Mar 2026 was $181.1 million, a 13.2% decrease from a year earlier, with the FY2025 full-year figure at $175.2 million, up 9904.23% from the prior year.
- Intangibles rose to $181.1 million in Q1 2026 per HROW's latest filing, from $175.2 million in the prior quarter.
- Across five years, Intangibles topped out at $208.7 million in Q3 2025 and bottomed at $1.5 million in Q2 2025.
- The 5-year median for Intangibles is $154.9 million (2024), against an average of $106.7 million.
- Biggest YoY gain for Intangibles was 9904.23% in 2025; the steepest drop was 99.05% in 2025.
- Year by year, Intangibles stood at $23.7 million in 2022, then soared by 574.0% to $159.9 million in 2023, then sank by 98.9% to $1.8 million in 2024, then surged by 9904.23% to $175.2 million in 2025, then rose by 3.36% to $181.1 million in 2026.
- Per Business Quant, the three latest HROW Intangibles figures stand at $181.1 million (Q1 2026), $175.2 million (Q4 2025), and $208.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 181.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.05 Mn |
| Dec 31, 2025 | 175.17 Mn |
| Sep 30, 2025 | 208.74 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 208.59 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 189.27 Mn |
| Jun 30, 2024 | 154.88 Mn |
| Mar 31, 2024 | 171.96 Mn |
| Dec 31, 2023 | 159.91 Mn |
| Sep 30, 2023 | 162.70 Mn |
| Jun 30, 2023 | 2.14 Mn |
| Mar 31, 2023 | 151.99 Mn |
| Dec 31, 2022 | 23.73 Mn |
| Sep 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 16.55 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 1.88 Mn |